Protocols

Based on the limited available evidence, dosing protocols for magnesium L-threonate are not well-established in peer-reviewed literature. The evidence base is sparse, with most information coming from clinical trial registrations rather than published results.

Current Clinical Trial Approaches:

Several clinical trials have investigated magnesium L-threonate, but specific dosing details are not available from the trial registrations provided. Studies have examined its use in:

Early Alzheimer's disease (Phase 2 trials)
Sleep and athletic performance in collegiate athletes
Stress and sleep supplementation combinations
Dosage comparisons in older adults

Preclinical Findings:

One comparative study (PMID: 42084749) examined magnesium-L-threonate versus magnesium-acetyl-taurate for neurophysiological benefits, focusing on bioavailability and cognitive functions. However, specific dosing protocols from this research are not detailed in the available evidence.

Another study (PMID: 41985648) investigated magnesium-L-threonate for bladder overactivity in a cyclophosphamide-induced cystitis model, but again, specific dosing information is not provided in the available abstracts.

Evidence Limitations:

The current evidence base lacks published, peer-reviewed protocols for magnesium L-threonate dosing in humans. Most clinical trials are either ongoing, not yet recruiting, or completed without published results available in this evidence set.

Disclaimer: This information is for educational purposes only and does not constitute personalized medical advice. Dosing of any supplement should be determined in consultation with a qualified healthcare provider who can assess individual needs, potential interactions, and safety considerations.

Magnesium Threonate

Member access required